ADVM
Price:
$4.17
Market Cap:
$92.06M
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; Cornell University; GenSight; Lexeo; and Virovek. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorpor...[Read more]
Industry
Biotechnology
IPO Date
2014-07-31
Stock Exchange
NASDAQ
Ticker
ADVM
According to Adverum Biotechnologies, Inc.’s latest financial reports and current stock price. The company's current ROE is -3844.85%. This represents a change of -23629.52% compared to the average of 16.34% of the last 4 quarters.
The mean historical ROE of Adverum Biotechnologies, Inc. over the last ten years is -66.47%. The current -3844.85% ROE has changed 5.68% with respect to the historical average. Over the past ten years (40 quarters), ADVM's ROE was at its highest in in the June 2025 quarter at 243.29%. The ROE was at its lowest in in the March 2025 quarter at -177.95%.
Average
-66.47%
Median
-41.44%
Minimum
-185.15%
Maximum
-18.79%
Discovering the peaks and valleys of Adverum Biotechnologies, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 180.83%
Maximum Annual ROE = -18.79%
Minimum Annual Increase = -42.17%
Minimum Annual ROE = -185.15%
| Year | ROE | Change |
|---|---|---|
| 2024 | -185.15% | 26.55% |
| 2023 | -146.30% | 71.85% |
| 2022 | -85.14% | 84.96% |
| 2021 | -46.03% | 70.14% |
| 2020 | -27.05% | -26.60% |
| 2019 | -36.86% | 2.09% |
| 2018 | -36.10% | 18.33% |
| 2017 | -30.51% | -42.17% |
| 2016 | -52.76% | 180.83% |
| 2015 | -18.79% | 10.54% |
The current ROE of Adverum Biotechnologies, Inc. (ADVM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-138.86%
5-year avg
-97.93%
10-year avg
-66.47%
Adverum Biotechnologies, Inc.’s ROE is greater than Artiva Biotherapeutics, Inc. (-45.64%), greater than Fractyl Health, Inc. Common Stock (-3645.22%), less than Sutro Biopharma, Inc. (861.99%), greater than Precision BioSciences, Inc. (-213.79%), greater than Metagenomi, Inc. Common Stock (-38.76%), greater than ALX Oncology Holdings Inc. (-115.67%), greater than aTyr Pharma, Inc. (-100.11%), greater than Biomea Fusion, Inc. (-256.98%), greater than Pliant Therapeutics, Inc. (-71.51%), greater than Quince Therapeutics, Inc. (-186.08%),
| Company | ROE | Market cap |
|---|---|---|
| -45.64% | $92.66M | |
| -3645.22% | $142.94M | |
| 861.99% | $79.86M | |
| -213.79% | $66.54M | |
| -38.76% | $67.21M | |
| -115.67% | $74.28M | |
| -100.11% | $81.11M | |
| -256.98% | $70.80M | |
| -71.51% | $80.50M | |
| -186.08% | $200.45M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Adverum Biotechnologies, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Adverum Biotechnologies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Adverum Biotechnologies, Inc.'s ROE?
How is the ROE calculated for Adverum Biotechnologies, Inc. (ADVM)?
What is the highest ROE for Adverum Biotechnologies, Inc. (ADVM)?
What is the 3-year average ROE for Adverum Biotechnologies, Inc. (ADVM)?
What is the 5-year average ROE for Adverum Biotechnologies, Inc. (ADVM)?
How does the current ROE for Adverum Biotechnologies, Inc. (ADVM) compare to its historical average?